{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:42:20Z","timestamp":1791931340252,"version":"4.3.4"},"reference-count":88,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,1,16]]},"abstract":"<jats:p>Background: Apolipoprotein E4 (APOE4) is the most prevalent genetic risk factor of Alzheimer\u2019s disease. Several studies suggest that APOE4 binding to its receptors is associated with their internalization and accumulation in intracellular compartments. Importantly, this phenomenon also occurs with other, non-ApoE receptors. Based on these observations, we hypothesized that APOE4 pathological effects are mediated by impairment in the life cycle of distinct receptors (APOER2, LRP1, IR, VEGFR). Objective: To examine the effects of APOE genotype on receptors protein levels and compartmentalization. Methods: Primary mouse neurons were prepared from APOE3 or APOE4 targeted replacement mice, or APOE-KO mice. Specific receptors protein levels were evaluated in these neurons, utilizing immunofluorescent staining. Additionally, surface membrane protein levels of those receptors were assessed by cell surface biotinylation assay and ELISA. Receptors\u2019 colocalization with intracellular compartments was assessed by double staining and confocal microscopy, followed by colocalization analysis. Finally, LRP1 or APOER2 were knocked-down with CRISPR\/Cas9 system to examine their role in mediating APOE4 effects on the receptors. Results: Our results revealed lower receptors\u2019 levels in APOE4, specifically on the membrane surface. Additionally, APOE4 affects the compartmentation of these receptors in two patterns: the first was observed with LRP1 and was associated with decreased receptor levels in numerous intracellular compartments. The second was obtained with the other receptors and was associated with their accumulation in early endosomes and their decrease in the late endosomes. Conclusions: These results provide a unifying mechanism, in which APOE4 drives the down regulation of various receptors, which plays important roles in distinct APOE4 related pathological processes.<\/jats:p>","DOI":"10.3233\/jad-230514","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T12:06:59Z","timestamp":1704802019000},"page":"753-775","source":"Crossref","is-referenced-by-count":7,"title":["The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"97","author":[{"given":"Mirna","family":"Safieh","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Sagol School of Neurosciences, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Liraz","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Sagol School of Neurosciences, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Ovadia","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Sagol School of Neurosciences, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Michaelson","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Sagol School of Neurosciences, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230514_ref1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","article-title":"APOE4: An emerging therapeutic target for Alzheimer\u2019s disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med"},{"key":"10.3233\/JAD-230514_ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11882-013-0417-1","article-title":"Etiology and pathogenesis of late-onset Alzheimer\u2019s disease","volume":"14","author":"Balin","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.3233\/JAD-230514_ref3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","article-title":"The genetics of Alzheimer\u2019s disease","volume":"107","author":"Bertram","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-230514_ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.32499","article-title":"Genomic variants, genes, and pathways of Alzheimer\u2019s disease: An overview","volume":"174","author":"Naj","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.3233\/JAD-230514_ref5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-981-32-9721-0_3","article-title":"Genetic markers of Alzheimer\u2019s disease","volume":"1192","author":"Nikolac Perkovic","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.3233\/JAD-230514_ref6","doi-asserted-by":"crossref","first-page":"254954","DOI":"10.1155\/2013\/254954","article-title":"Genetics of Alzheimer\u2019s disease","volume":"2013","author":"Ridge","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.3233\/JAD-230514_ref7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.288.6422.961","article-title":"Neurochemical characteristics of early and late onset types of Alzheimer\u2019s disease","volume":"288","author":"Rossor","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.3233\/JAD-230514_ref8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","article-title":"Apolipoprotein E and Alzheimer\u2019s disease","volume":"19","author":"Strittmatter","year":"1996","journal-title":"Ann Rev Neurosci"},{"key":"10.3233\/JAD-230514_ref9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00005072-199409000-00002","article-title":"Apolipoprotein E affects the rate of Alzheimer disease expression: Beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease","volume":"53","author":"Roses","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-230514_ref11","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.3390\/ijms19113479","article-title":"Apoprotein E and reverse cholesterol transport","volume":"19","author":"Getz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230514_ref12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins: ApoE and regulation of cholesterol metabolism","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-230514_ref13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/JMN:23:3:219","article-title":"Cholesterol efflux as a critical component of Alzheimer\u2019s disease pathogenesis","volume":"23","author":"Rebeck","year":"2004","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-230514_ref14","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-230514_ref15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.14348\/molcells.2014.0248","article-title":"Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: Potential cellular and molecular mechanisms","volume":"37","author":"Kim","year":"2014","journal-title":"Mol Cells"},{"key":"10.3233\/JAD-230514_ref16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MOL.0000000000000383","article-title":"Apolipoprotein E metabolism and functions in brain and its role in Alzheimer\u2019s disease","volume":"28","author":"Liao","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.3233\/JAD-230514_ref17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neurobiolaging.2014.03.037","article-title":"Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer\u2019s disease","volume":"35 Suppl 2","author":"Poirier","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-230514_ref18","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: Pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230514_ref19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer\u2019s disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-230514_ref20","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1038\/s41598-017-14204-3","article-title":"CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in-positive Alzheimer\u2019s disease","volume":"7","author":"Koch","year":"2017","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230514_ref21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1515\/CCLM.2011.088","article-title":"The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer\u2019s disease","volume":"49","author":"Leoni","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-230514_ref22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-12-394625-6.00007-6","article-title":"Mitochondrial dysfunction: Cause and consequence of Alzheimer\u2019s disease","volume":"127","author":"Friedland-Leuner","year":"2014","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-230514_ref23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1326-8-16","article-title":"induces A\u03b242, tau, and neuronal pathology in the hippocampus of young targeted replacementmice","volume":"8","author":"Liraz","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-230514_ref24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2174\/1567205013666160415154550","article-title":"induces site-specific tau phosphorylation through calpain-CDK5 signaling pathway in EFAD-Tg mice","volume":"13","author":"Zhou","year":"2016","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-230514_ref25","doi-asserted-by":"crossref","first-page":"27876","DOI":"10.1074\/jbc.M112.377549","article-title":"Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress","volume":"287","author":"Cash","year":"2012","journal-title":"JBiol Chem"},{"key":"10.3233\/JAD-230514_ref26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12264-013-1422-z","article-title":"Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer\u2019s disease","volume":"30","author":"Dorey","year":"2014","journal-title":"Neurosci Bull"},{"key":"10.3233\/JAD-230514_ref27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jss.2014.06.051","article-title":"Effects of three hydrogen-rich liquids on hemorrhagic shock in rats","volume":"193","author":"Du","year":"2015","journal-title":"J Surg Res"},{"key":"10.3233\/JAD-230514_ref28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.nbd.2005.05.002","article-title":"Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade","volume":"20","author":"Ophir","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-230514_ref29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.arcmed.2018.08.008","article-title":"Apolipoprotein E in cardiovascular diseases: Novel aspects ofan old-fashioned enigma","volume":"49","author":"Liehn","year":"2018","journal-title":"Arch Med Res"},{"key":"10.3233\/JAD-230514_ref30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1194\/jlr.R300007-JLR200","article-title":"Cholesterol: From heart attacks to Alzheimer\u2019s disease","volume":"44","author":"Raffai","year":"2003","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-230514_ref31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp-2013-306485","article-title":"APOE associations with severe CAA-associated vasculopathic changes: Collaborative meta-analysis","volume":"85","author":"Rannikmae","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-230514_ref32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230514_ref33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","article-title":"Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer\u2019s disease and tauopathies","volume":"128","author":"Yarchoan","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-230514_ref34","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-230514_ref35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0404.2006.00775.x","article-title":"Low serum VEGF levels are associated with Alzheimer\u2019s disease","volume":"116","author":"Mateo","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-230514_ref36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-160182","article-title":"Reversal of-driven brain pathology by vascular endothelial growth factor treatment","volume":"53","author":"Salomon-Zimri","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230514_ref37","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1194\/jlr.R075507","article-title":"The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease","volume":"58","author":"Lane-Donovan","year":"2017","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-230514_ref38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-230514_ref39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-230514_ref40","doi-asserted-by":"crossref","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-230514_ref41","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1074\/jbc.M500613200","article-title":"Rapid endocytosis of the low density lipoprotein receptor-related protein modulates cell surface distribution and processing of the beta-amyloid precursor protein","volume":"280","author":"Cam","year":"2005","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230514_ref42","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/ijms19103090","article-title":"The Reelin receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL receptor","volume":"19","author":"Dlugosz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230514_ref43","doi-asserted-by":"crossref","first-page":"21909","DOI":"10.1074\/jbc.M112.444364","article-title":"Low density lipoprotein receptor-related protein 1 (LRP1) modulates N-methyl-D-aspartate (NMDA) receptor-dependent intracellular signaling and NMDA-induced regulation of postsynaptic protein complexes","volume":"288","author":"Nakajima","year":"2013","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230514_ref44","doi-asserted-by":"crossref","first-page":"14308","DOI":"10.1074\/jbc.M109.046672","article-title":"Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activation of the MAPK pathway","volume":"285","author":"Muratoglu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230514_ref45","doi-asserted-by":"crossref","first-page":"e113237","DOI":"10.1371\/journal.pone.0113237","article-title":"Low-density lipoprotein receptor-related protein 1 (LRP1) regulates the stability and function of GluA1 \u03b1-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor in neurons","volume":"9","author":"Gan","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-230514_ref46","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-230514_ref47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-190914","article-title":"Carnosic acid reverses the inhibition ofon cell surface level of ApoER2 and Reelin signaling pathway","volume":"73","author":"Feng","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-230514_ref48","doi-asserted-by":"crossref","first-page":"e40048","DOI":"10.7554\/eLife.40048","article-title":"Reversal of-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease","volume":"7","author":"Xian","year":"2018","journal-title":"Elife"},{"key":"10.3233\/JAD-230514_ref49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/1567205010666131119232444","article-title":"Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of APOE4 in vivo","volume":"11","author":"Gilat-Frenkel","year":"2014","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-230514_ref50","doi-asserted-by":"crossref","first-page":"e29385","DOI":"10.1371\/journal.pone.0029385","article-title":"Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of Apolipoprotein E","volume":"7","author":"Laatsch","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-230514_ref51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","article-title":"The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer\u2019s disease","volume":"6","author":"Kanekiyo","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-230514_ref52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: A systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-230514_ref53","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-230514_ref54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-230514_ref55","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-150348","article-title":"Human ApoE isoforms differentially modulate glucose and amyloid metabolic pathways in female brain: Evidence of the mechanism of neuroprotection by ApoE2 and implications for Alzheimer\u2019s disease prevention and early intervention","volume":"48","author":"Keeney","year":"2015","journal-title":"Alzheimers Dis"},{"key":"10.3233\/JAD-230514_ref56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuron.2017.09.003","article-title":"Apolipoprotein E4 impairs neuronal insulin signaling by trapping insulin receptor in the endosomes","volume":"96","author":"Zhao","year":"2017","journal-title":"Neuron"},{"key":"10.3233\/JAD-230514_ref57","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1523\/JNEUROSCI.5180-14.2015","article-title":"Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain","volume":"35","author":"Liu","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230514_ref58","first-page":"213","article-title":"An inside view: VEGF receptor trafficking and signaling","volume":"27","author":"Simons","year":"2012","journal-title":"Physiology (Bethesda)"},{"key":"10.3233\/JAD-230514_ref59","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00018-013-1280-x","article-title":"Delineating multiple functions of VEGF-A in the adult brain","volume":"70","author":"Licht","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-230514_ref60","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/cells3020363","article-title":"Endosome-to-plasma membrane recycling of VEGFR2 receptor tyrosine kinase regulates endothelial function and blood vessel formation","volume":"3","author":"Jopling","year":"2014","journal-title":"Cells"},{"key":"10.3233\/JAD-230514_ref61","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1523\/JNEUROSCI.5633-07.2008","article-title":"Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits","volume":"28","author":"Belinson","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230514_ref62","first-page":"1","article-title":"The effects of apolipoprotein E genotype, \u03b1-synuclein deficiency, and sex on brain synaptic and Alzheimer\u2019s disease-related pathology","volume":"10","author":"Bar","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-230514_ref63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7237-1_15","article-title":"Isolation, purification, and culture of primary murine sensory neurons","volume":"1656","author":"Katzenell","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.3233\/JAD-230514_ref64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1267\/ahc.07002","article-title":"Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: Pushing pixels to explore biological phenomena","volume":"40","author":"Zinchuk","year":"2007","journal-title":"Acta Histochem Cytochem"},{"key":"10.3233\/JAD-230514_ref65","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/cyto.a.20896","article-title":"Quantifying colocalization by correlation: The pearson correlation coefficient is superior to the Mander\u2019s overlap coefficient","volume":"77","author":"Adler","year":"2010","journal-title":"Cytometry A"},{"key":"10.3233\/JAD-230514_ref66","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"10.3233\/JAD-230514_ref67","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-230514_ref68","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/ATVBAHA.116.307023","article-title":"Central nervous system lipoproteins","volume":"36","author":"Mahley","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-230514_ref69","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2021.01.005","article-title":"Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory","volume":"109","author":"Li","year":"2021","journal-title":"Neuron"},{"key":"10.3233\/JAD-230514_ref70","doi-asserted-by":"crossref","first-page":"734001","DOI":"10.3389\/fnins.2021.734001","article-title":"Astrocytic and neuronal apolipoprotein E isoforms differentially affect neuronal excitability","volume":"15","author":"Konings","year":"2021","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-230514_ref71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-022-01006-x","article-title":"Chimeric cerebral organoids reveal the essentials of neuronal and astrocyticfor Alzheimer\u2019s tau pathology","volume":"7","author":"Huang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.3233\/JAD-230514_ref72","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12017-018-8480-3","article-title":"Differential binding of human ApoE isoforms to insulin receptor is associated with aberrant insulin signaling in AD brain samples","volume":"20","author":"Chan","year":"2018","journal-title":"Neuromol Med"},{"key":"10.3233\/JAD-230514_ref73","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biochi.2005.10.007","article-title":"Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes","volume":"88","author":"Rapp","year":"2006","journal-title":"Biochimie"},{"key":"10.3233\/JAD-230514_ref74","doi-asserted-by":"crossref","first-page":"50380","DOI":"10.1074\/jbc.M204898200","article-title":"Apolipoprotein E4 forms a molten globule: A potential basis for its association with disease","volume":"277","author":"Morrow","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-230514_ref75","doi-asserted-by":"crossref","first-page":"e72034","DOI":"10.7554\/eLife.72034","article-title":"NHE6 depletion corrects-mediated synaptic impairments and reduces amyloid plaque load","volume":"10","author":"Pohlkamp","year":"2021","journal-title":"eLife"},{"key":"10.3233\/JAD-230514_ref76","doi-asserted-by":"crossref","first-page":"13842","DOI":"10.1038\/srep13842","article-title":"Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice","volume":"5","author":"Chan","year":"2015","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-230514_ref77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2013.07.032","article-title":"VEGF activates NR2B phosphorylation through Dab1 pathway","volume":"552","author":"Howell","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-230514_ref78","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/MCB.26.2.605-616.2006","article-title":"Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal Fetal development","volume":"26","author":"Roebroek","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.3233\/JAD-230514_ref79","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: A multifunctional scavenger and signaling receptor","volume":"108","author":"LHerz","year":"2001","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-230514_ref80","doi-asserted-by":"crossref","first-page":"E6640","DOI":"10.1073\/pnas.1801612115","article-title":"Amyloid clearance defect inastrocytes is reversed by epigenetic correction of endosomal pH. ,","volume":"115","author":"Prasad","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-230514_ref81","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/ijms21041289","article-title":"Central and peripheral mechanisms in-driven diabetic pathology","volume":"21","author":"Koren-Iton","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-230514_ref82","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3233\/JAD-191068","article-title":"Diabetes mellitus increases risk of incident dementia inAPOE\u025b4 carriers: A meta-analysis","volume":"74","author":"Li","year":"2020","journal-title":"J AlzheimersDis"},{"key":"10.3233\/JAD-230514_ref83","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00401-016-1547-z","article-title":"The role of APOE in cerebrovascular dysfunction","volume":"131","author":"Tai","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-230514_ref84","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: Implications for Alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-230514_ref85","first-page":"3504","article-title":"Is apolipoprotein E4 an important risk factor for vascular dementia?","volume":"7","author":"Rohn","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.3233\/JAD-230514_ref86","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/01.CCM.0000080484.72004.C4","article-title":"Relationship betweenallele and excitatory amino acid levels after traumatic brain injury","volume":"31","author":"Kerr","year":"2003","journal-title":"Crit Care Med"},{"key":"10.3233\/JAD-230514_ref87","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1074\/mcp.M115.056580","article-title":"Apolipoprotein E*4 (APOE*4) genotype is associated with altered levels of glutamate signaling proteins and synaptic coexpression networks in the prefrontal cortex in mild to moderate Alzheimer disease","volume":"15","author":"Sweet","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"10.3233\/JAD-230514_ref88","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","article-title":"Reversal of-driven brain pathology and behavioral deficits by bexarotene","volume":"34","author":"Boehm-Cagan","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-230514_ref89","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 agonist reverses the-driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan","year":"2016","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:06Z","timestamp":1777370946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":88,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-230514","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]}}}